Low Dose of Rapamycin/IL-2 Treatment Protect Human Islet Allograft from Rejection in a Humanized Diabetic Mouse Model (#161)
Min Hu
1
,
Wayne J HAWTHORNE
1
,
Heather BURNS
1
,
Hei NAN
1
,
Jingjing WU
1
,
Sussan DAVIES
1
,
David LIUWANTARA
1
,
Joanne HAWKES
1
,
Yi Wen QIAN
1
,
Lindy WILLIAMS
1
,
Tina PATEL
1
,
Elvira JIMENEZ-VERA
1
,
Katie HOR
1
,
Ya Wang
1
,
Yuan Min WANG
2
,
Geoff Y ZHANG
2
,
Shounan YI
1
,
Stephen I ALEXANDER
2
,
Philip O'Connell
1
- Westmead Millennium Institute, University of Sydney, Westmead, NSW, Australia
- Centre for Kidney Research, Children's Hospital at Westmead, University of Sydney, Westmead, NSW, Australia